Welcome to our dedicated page for UDHI news (Ticker: UDHI), a resource for investors and traders seeking the latest updates and insights on UDHI stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect UDHI's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of UDHI's position in the market.
Xcelerate (OTC: UDHI) announced the appointment of Nobel Prize laureate Dr. Barry Marshall to its Advisory Board, effective immediately. Dr. Marshall is recognized for his discovery of Helicobacter pylori and its link to peptic ulcer disease and stomach cancer. CEO Michael O'Shea stated that Dr. Marshall's expertise will significantly boost the company's transition towards business development and its goal of a NASDAQ listing. Xcelerate aims to merge innovative technology with early-stage medtech companies for controlled clinical applications, enhancing product profitability and return on investment.
Xcelerate, Inc. (OTC: UDHI) has appointed Dr. Dilan Ellegala to its Advisory Board, effective immediately. Dr. Ellegala is a distinguished neurosurgeon and medical innovator with extensive experience in med-tech commercialization. He has held significant academic roles, authored over 50 research publications, and founded successful medical companies, including Sonospine LLC. CEO Michael O'Shea expressed that Dr. Ellegala’s expertise will be pivotal in advancing Xcelerate’s business development and acquisition efforts, marking an important transition for the company.
Union Dental Holdings, Inc. (UDHI) has signed a final Licensing Agreement with Consulting Group of Jocassee, Inc. (CGJI) to acquire worldwide rights to CGJI's Patent #10,718,586, covering medical device design and distribution. This Agreement includes a new Patent Application #17/017,546, enhancing CGJI's existing patent portfolio. UDHI aims to market these patented products swiftly, anticipating significant revenue in FY2021. CEO Michael O'Shea emphasized the collaborative effort behind this deal, positioning UDHI for potential NASDAQ listing.
Union Dental Holdings (UDHI) announced a Preliminary Agreement with Consulting Group of Jocassee for the licensing of Patent #10,718,586, related to metals used in medical devices. This patent is expected to provide immediate commercial viability in the medical field. CEO Michael O'Shea stated this agreement positions UDHI for significant revenue generation as part of its international growth strategy. The new Chief Science Officer, Dr. Anja Glisovic, will lead efforts in leveraging the patent's applications.
Union Dental Holdings, Inc. (OTC: UDHI) has appointed Dr. Anja Glisovic as Chief Science Officer, effective immediately. Dr. Glisovic brings extensive research experience and numerous patents in medical devices and chemical engineering. Her initial role will focus on identifying high-growth opportunities in the medical sector. Dr. Glisovic earned her PhD from Georg-August Universität in Germany and has held leadership positions at the Fraunhofer Institute, a key player in applied research. This leadership addition is part of UDHI's strategy to transition into a business suitable for NASDAQ listing.
Union Dental Holdings, Inc. (OTC: UDHI) announced a restructuring initiative with the appointment of forensic accountant Michael O'Shea as the new CEO. O'Shea aims to transition the company from its status as a 'public shell' since its Florida 727 filing in January 2016. He has also added a new Securities Attorney and two Board members. The company launched NewUDHI.com for real-time updates on its restructuring process, while TransMedia Group has been retained for public relations. The CEO emphasizes ongoing improvements and plans for transparency.
